Simple steps you can take to reduce your risk for heart failure. Plus, how to work with your health professional to manage it once you’ve been diagnosed.

A review of how far GLP-1 agonists have come – drugs for type 2 diabetes that help with not only blood sugar management, but with weight loss and heart health too

Siren’s machine washable, dryable socks use temperature monitoring as a convenient way to alert users of potential injuries and help prevent complications

Farxiga becomes the first SGLT-2 inhibitor drug approved to reduce the risk of hospitalization for heart failure in adults who have type 2 diabetes and heart disease or...

When first diagnosed, Renza was told to fear diabetes complications. This clouded her ability to do even the most basic of self-management

Farxiga’s heart health benefits were the same in people with and without diabetes, as well as across a spectrum of baseline A1C levels

diaTribe Community Manager, Cherise Shockley, shares the story of her diabetes diagnosis and how that diagnosis affected her family

New guidelines from ADA and EASD focus on GLP-1 agonists and SGLT-2 inhibitors to improve heart and kidney health

Are people aware of the link between diabetes and heart health? Do they know that certain diabetes drugs may protect the heart? Is heart health commonly discussed with...

Try googling “prediabetes” or “type 2 diabetes” — a new search feature in the United States automatically spotlights the CDC’s one-minute prediabetes risk test

A rarely used benefit: Medicare covers up to three hours of personal nutrition counseling for people with diabetes and/or kidney disease after healthcare professional...

Maria shares her experiences and strategies for managing blood sugar levels while studying abroad

A new pill combines Jardiance, Tradjenta, and metformin to help people with type 2 diabetes manage blood glucose levels more easily, and in many different ways

Regular eye screenings are important for people with diabetes. Learn more about diabetes-related retinopathy screenings from diabetes advocates Renza and Grumpy

Ozempic, a once weekly injectable GLP-1 agonist drug, is now approved to reduce the risk of heart attack and stroke. Rybelsus (a pill version of Ozempic) is confirmed to...

The first of its kind, Why WAIT is a creative app-based approach to weight loss and diabetes management

The SGLT-2 inhibitor becomes the first diabetes medicine approved to treat kidney disease and reduce the risk of hospitalization for heart failure in people with type 2...

Results from the VERTIS-CV trial show that SGLT-2 inhibitor Steglatro benefits heart and kidney health; hear expert opinions on SGLT-2 and GLP-1 medications

In exciting news for digital diabetes prevention programs, a new study showed that highly engaged participants – those who more frequently engaged in food logging,...

Trulicity can now be prescribed to reduce the risk of stroke and heart attack in adults with type 2 diabetes and with heart disease or those who at risk for heart disease